The new test could signal whether treatment is working months earlier than standard imaging scans, allowing doctors to try alternatives sooner, initial results show.
Demsky joined the University of Michigan Rogel Cancer Center communications team in 2019. Prior to that he served as director of communications for the University of Michigan's Life Sciences Institute and science editor for Medicine at Michigan Magazine. Contact: firstname.lastname@example.org
Activity of the polycomb repressive complex 1 is essential for the development and maintenance of leukemic cells; disrupting it presents a new potential therapeutic approach.
BET inhibitors show promise in overcoming lineage plasticity, a newly recognized form of resistance to prostate cancer drugs
Some prostate tumors transition from being glandular to more nerve-like in response to drugs that block the androgen receptor; a new preclinical study examines the underlyin
Statewide quality improvement project reduced excessive radiation treatments for bone metastases by 80%
The effort by the Michigan Radiation Oncology Quality Consortium reduced unnecessary medical procedures, and saved the time and resources of patients and families.
Trial will evaluate the safety and efficacy of histotripsy against liver tumors at eight U.S. sites.
Cholesterol-carrying protein found to help suppress immune response in pancreatic tumor microenvironment
ApoE has known roles in cardiovascular disease and Alzheimer’s, but was not previously implicated in pancreatic cancer.